Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society, 33228 [07-2963]
Download as PDF
<![CDATA[
33228
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
issues. The draft meeting agenda and
other information about SACGHS,
including information about access to
the Web cast, will be available at the
following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
jlentini on PROD1PC65 with NOTICES
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice is hereby given of the thirteenth
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
on Tuesday, July 10, 2007, from 8:30
a.m. to approximately 5 p.m. in Room
800 of the Hubert H. Humphrey
Building, 200 Independence Avenue,
SW., Washington, DC 20001. The
meeting will be open to the public with
attendance limited to space available.
The meeting also will be Web cast.
The meeting will focus primarily on
the issue of gene patents and licensing
practices and consist of a series of
presentations and discussions involving
international experts on how other
countries are addressing questions
related to the impact of gene patents and
licensing practices on patient access to
genetic tests. In addition, the SACGHS
task force on oversight of genetic testing
will present a brief report on the
progress of its fact-finding and
consultative efforts with regard to the
Secretary’s charge. The Committee will
also be updated about the public
comments received in response to the
Committee’s solicitation on its draft
report on pharmacogenomics.
Time will be provided for public
comments. The Committee would
welcome hearing from anyone wishing
to provide public comment on any issue
related to genetics, health, and society.
Individuals who would like to provide
public comment should notify the
SACGHS Executive Secretary, Ms. Sarah
Carr, by telephone at 301–496–9838 or
e-mail at carrs@od.nih.gov. The
SACGHS office is located at 6705
Rockledge Drive, Suite 750, Bethesda,
MD 20892. Anyone planning to attend
the meeting who is in need of special
assistance, such as sign language
interpretation or other reasonable
accommodations, is also asked to
contact the Executive Secretary.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
and genomic technologies and, as
warranted, to provide advice on these
VerDate Aug<31>2005
19:26 Jun 14, 2007
Jkt 211001
Dated: June 7, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2963 Filed 6–14–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Toxicology Program (Ntp);
Center for the Evaluation of Risks to
Human Reproduction (CERHR);
Announcement of the Second
Bisphenol A Expert Panel Meeting
National Institute of
Environmental Health Sciences
(NIEHS); National Institutes of Health.
AGENCY:
Meeting announcement and
request for comments.
ACTION:
SUMMARY: CERHR announces the second
meeting of the CERHR Expert Panel on
Bisphenol A on August 6–8, 2007, at the
Hilton Alexandria Old Town in
Alexandria, VA. This meeting is open to
the public with time scheduled for oral
public comment. Attendance is limited
only by the available meeting space.
The second expert panel meeting
on bisphenol A will be held August 6–
8, 2007. The interim draft expert panel
report containing sections 1–4 is
currently available for public comment
[Federal Register, May 1, 2007 (Vol. 72,
No. 83, pages 23833–4)]. Written public
comments on the interim draft report
must be received by June 20, 2007. July
30, 2007 is the deadline for preregistration to attend the meeting, to
pre-register to provide oral comments,
and to submit written materials
intended to supplement the oral
remarks.
DATES:
The second expert panel
meeting will be held at the Hilton
Alexandria Old Town, 1767 King Street,
Alexandria, VA (located across the
street from the King Street Metro Stop).
Written comments should be sent to Dr.
Michael D. Shelby, CERHR Director
[NIEHS, P.O. Box 12233, MD EC–32,
Research Triangle Park, NC 27709
(mail), (919) 316–4511 (fax), or
shelby@niehs.nih.gov (e-mail)]. Courier
address: CERHR, 79 T.W. Alexander
Drive, Building 4401, Room 103,
Research Triangle Park, NC 27709.
ADDRESSES:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Dr.
Michael D. Shelby, CERHR Director,
919–541–3455, shelby@niehs.nih.gov.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
Background
CERHR convened the expert panel on
March 5–7, 2007 to complete its report
on the potential reproductive and
developmental hazards of bisphenol A.
The panel discussed and made revisions
to the draft expert panel report, but
because of the length and complexity of
this evaluation, the panel was unable to
complete its task. Information about the
meeting and the draft interim expert
panel report, which shows all edits to
date, are available on the CERHR Web
site (https://cerhr.niehs.nih.gov/
chemicals/bisphenol/bisphenol.html).
The expert panel will reconvene on
August 6–8, 2007, for a second meeting
at the Hilton Alexandria Old Town,
1767 King Street, Alexandria, VA. The
meeting will begin each day at 8:30 a.m.
and continue until adjournment. It is
anticipated to adjourn by noon on
August 8, although adjournment may
occur earlier or later depending upon
the time needed for the expert panel to
complete its work. The expert panel will
(1) continue its review, (2) finalize
sections 1–4 of the draft report, (3) reach
conclusions regarding whether exposure
to bisphenol A is a hazard to human
reproduction or development, and (4)
write Section 5 Summary, Conclusions,
and Critical Data Needs. The interim
draft report will serve as the starting
point for the expert panel’s discussions
at its August meeting.
Bisphenol A (CAS RN: 80–5–07) is a
high production volume chemical used
in the production of epoxy resins,
polyester resins, polysulfone resins,
polyacrylate resins, polycarbonate
plastics, and flame retardants.
Polycarbonate plastics are used in food
and drink packaging; resins are used as
lacquers to coat metal products such as
food cans, bottle tops, and water supply
pipes. Some polymers used in dental
sealants and tooth coatings contain
bisphenol A. Exposure to the general
population can occur through direct
contact to bisphenol A or by exposure
to food or drink that has been in contact
with a material containing bisphenol A.
CERHR selected this chemical for
evaluation because of (1) high
production volume, (2) widespread
human exposure, (3) evidence of
reproductive toxicity in laboratory
animal studies, and (4) public concern.
Request for Comments
The CERHR again invites written
public comments on the interim draft
expert panel report on bisphenol A. All
E:\FR\FM\15JNN1.SGM
15JNN1
]]>Agencies
[Federal Register Volume 72, Number 115 (Friday, June 15, 2007)]
[Notices]
[Page 33228]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2963]
[[Page 33228]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Notice of Meeting: Secretary's Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92-463, notice is hereby given of the
thirteenth meeting of the Secretary's Advisory Committee on Genetics,
Health, and Society (SACGHS), U.S. Public Health Service. The meeting
will be held from on Tuesday, July 10, 2007, from 8:30 a.m. to
approximately 5 p.m. in Room 800 of the Hubert H. Humphrey Building,
200 Independence Avenue, SW., Washington, DC 20001. The meeting will be
open to the public with attendance limited to space available. The
meeting also will be Web cast.
The meeting will focus primarily on the issue of gene patents and
licensing practices and consist of a series of presentations and
discussions involving international experts on how other countries are
addressing questions related to the impact of gene patents and
licensing practices on patient access to genetic tests. In addition,
the SACGHS task force on oversight of genetic testing will present a
brief report on the progress of its fact-finding and consultative
efforts with regard to the Secretary's charge. The Committee will also
be updated about the public comments received in response to the
Committee's solicitation on its draft report on pharmacogenomics.
Time will be provided for public comments. The Committee would
welcome hearing from anyone wishing to provide public comment on any
issue related to genetics, health, and society. Individuals who would
like to provide public comment should notify the SACGHS Executive
Secretary, Ms. Sarah Carr, by telephone at 301-496-9838 or e-mail at
carrs@od.nih.gov. The SACGHS office is located at 6705 Rockledge Drive,
Suite 750, Bethesda, MD 20892. Anyone planning to attend the meeting
who is in need of special assistance, such as sign language
interpretation or other reasonable accommodations, is also asked to
contact the Executive Secretary.
Under authority of 42 U.S.C. 217a, Section 222 of the Public Health
Service Act, as amended, the Department of Health and Human Services
established SACGHS to serve as a public forum for deliberations on the
broad range of human health and societal issues raised by the
development and use of genetic and genomic technologies and, as
warranted, to provide advice on these issues. The draft meeting agenda
and other information about SACGHS, including information about access
to the Web cast, will be available at the following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
Dated: June 7, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-2963 Filed 6-14-07; 8:45 am]
BILLING CODE 4140-01-M
